NCT05576272 2023-11-22
A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma
Qilu Pharmaceutical Co., Ltd.
Phase 2/3 Unknown
Qilu Pharmaceutical Co., Ltd.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
National Cancer Centre, Singapore
Ain Shams University
National Cancer Institute, Egypt
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Sun Yat-sen University
National Cancer Center, Korea
Sun Yat-sen University
Samsung Medical Center
Sun Yat-sen University
Radboud University Medical Center
Cancer Hospital of Guizhou Province